About: Development of Small-Molecule MERS-CoV Inhibitors

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Development of Small-Molecule MERS-CoV Inhibitors Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	Development of Small-Molecule MERS-CoV Inhibitors
Creator	Jiang, Shibo Wang, Lili Ying, Tianlei Yu, Fei Deng, Xiaoqian He, Chen Hu, Lanfang Liang, Ruiying Su, Meng Su, Yudan Zhang, Naru
Source	Medline; PMC
abstract	Middle East respiratory syndrome coronavirus (MERS-CoV) with potential to cause global pandemics remains a threat to the public health, security, and economy. In this review, we focus on advances in the research and development of small-molecule MERS-CoV inhibitors targeting different stages of the MERS-CoV life cycle, aiming to prevent or treat MERS-CoV infection.
has issue date	2018-12-17(xsd:dateTime)
bibo:doi	10.3390/v10120721
bibo:pmid	30562987
has license	cc-by
sha1sum (hex)	f176cd025d08014cfb69f9d2b28e92b19a1a7522
schema:url	https://doi.org/10.3390/v10120721
resource representing a document's title	Development of Small-Molecule MERS-CoV Inhibitors
has PubMed Central identifier	PMC6316138
has PubMed identifier	30562987
schema:publication	Viruses
resource representing a document's body	covid:f176cd025d08014cfb69f9d2b28e92b19a1a7522#body_text
is schema:about of	named entity 'THREAT' named entity 'MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS' named entity 'INFECTION' named entity 'INHIBITORS' named entity 'SECURITY' named entity 'FOCUS' named entity 'DEVELOPMENT' named entity 'INHIBITORS' named entity 'MOLECULE' named entity 'VIRUSES' named entity 'MOLECULE' named entity 'TREAT' named entity 'GLOBAL' named entity 'TO PREVENT' named entity 'TARGETING' named entity 'RESEARCH AND DEVELOPMENT' named entity 'SMALL' named entity 'STAGES' named entity 'POTENTIAL' named entity 'SMALL' named entity 'LIFE CYCLE' named entity 'DIFFERENT' named entity 'CAUSE' named entity 'MERS-COV' named entity 'ECONOMY' named entity 'PANDEMICS' named entity 'PUBLIC HEALTH' named entity 'REVIEW' named entity 'public health' named entity 'pandemics' named entity 'MERS-CoV' named entity 'small-molecule' named entity 'Middle East respiratory syndrome coronavirus' named entity 'life cycle' named entity 'wild-type' named entity 'camostat' named entity 'LDH' named entity 'Asia' named entity 'intranasal administration' named entity 'HR1' named entity 'sugar' named entity 'virus entry' named entity 'host cells' named entity 'HR2' named entity 'cytoskeleton' named entity 'cell line' named entity 'dipeptidyl peptidase-4' named entity 'MERS-CoV' named entity 'GS-5734' named entity 'cytotoxicity' named entity 'infection' named entity 'MERS-CoV' named entity 'HR2' named entity 'MERS-CoV' named entity 'coronaviruses' named entity 'Huh-7' named entity 'HIV-1 protease' named entity 'viral envelope' named entity 'DMVs' named entity 'MRC-5' named entity 'N-terminal' named entity 'coronavirus' named entity 'MERS-CoV' named entity 'SARS-CoV' named entity 'MERS-CoV' named entity 'bronchus' named entity 'MERS-CoV' named entity 'sequencing data' named entity 'papain' named entity 'plasma membrane' named entity 'MERS-CoV'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software